Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 236 participants.

Also called NCT05556460

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 236 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05556460
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05556460. Randomized; single masking; primary purpose treatment. Start 2024-09-03 (actual); primary completion 2028-08-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
Condition
Tricuspid Regurgitation
Intervention (Device)
DragonFly-T Transcatheter Tricuspid Valve Repair System
Intervention (Drug)
Medical therapy
Lead sponsor
Hangzhou Valgen Medtech Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct05556460
Content hash
5118b18c339bc0e25d1f518dafba36dbe89df48c639b89525ef8d59856a6bff0